Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC